{"organizations": [], "uuid": "d0d3610723b4e969c5ab4fb69e9fa8a4b25ceb9b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/19/pr-newswire-global-cancer-cachexia-market-leading-players-to-focus-on-mergers-and-acquisitions-to-strengthen-product-portfolio-says-tmr.html", "country": "US", "domain_rank": 767, "title": "Global Cancer Cachexia Market: Leading Players to Focus on Mergers and Acquisitions to Strengthen Product Portfolio, Says TMR", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-19T15:30:00.000+02:00", "replies_count": 0, "uuid": "d0d3610723b4e969c5ab4fb69e9fa8a4b25ceb9b"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/19/pr-newswire-global-cancer-cachexia-market-leading-players-to-focus-on-mergers-and-acquisitions-to-strengthen-product-portfolio-says-tmr.html", "ord_in_thread": 0, "title": "Global Cancer Cachexia Market: Leading Players to Focus on Mergers and Acquisitions to Strengthen Product Portfolio, Says TMR", "locations": [], "entities": {"persons": [], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "albany", "sentiment": "none"}, {"name": "north america", "sentiment": "none"}], "organizations": [{"name": "focus on mergers", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ALBANY, New York, February 19, 2018 /PRNewswire/ --\nAccording to the research report, the global cancer cachexia market was worth US$1.63 bn in 2016. Research analyst at TMR expect the opportunity in this market to rise at a CAGR of 4.90% during the period from 2017 to 2025 and reach a value of US$2.51 bn by the end of the period of the forecast. Among the therapeutics available for the treatment of cancer cachexia, the demand for progestogens is comparatively higher and is expected to remain so over the next few years, thanks to their efficiency. Regionally, the market is led by North America. Researchers project this regional market to continue on the top in the near future on account of the rising awareness among people regarding cancer supportive care, notes the market study.\nGet PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15482\nIncreasing Prevalence of Cancer Cachexia to Offer Lucrative Opportunities to Market Players\nThe increasing prevalence of cachexia, especially in industrialized regions, such as North America, Europe, and Japan, is the main factor behind the significant growth of the market for cancer cachexia, worldwide. According to an estimation, currently, cachexia affects around nine million patients, globally, which is round about 1% of overall patient-pool across the world. This factor is expected to create more opportunities for existing participants and players, looking to enter the market over the next few years.\nThe strong product pipeline is another important factor that will support the growth of this market in the near future. \"With a promising clinical pipeline and imminent regulatory approvals, the global market for cancer cachexia is likely to report a substantial growth in the years to come, states the author of the research study.\nRequest a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=15482\nStringent Regulatory Requirements May Hamper Growth\nAlthough the worldwide market for cancer cachexia points towards a thriving future; its growth trajectory will not be smooth enough. The stringent regulatory requirements and the long procedure for FDA approval may dissuade the manufacturers of cancer cachexia drugs from investing in this market over the forthcoming years, which, in turn, will impede the growth of this market in the long run, states the research report.\nThe global cancer cachexia market demonstrates a considerably high competition among the leading players, finds a new research report by Transparency Market Research (TMR). The key vendors of cancer cachexia treatment solutions, globally, are actively involving in partnerships, mergers, and acquisitions with clinical trial companies in a bid to strengthen their product portfolios. They are likely to focus more on technological upgrades and introducing new therapeutics based on appetite stimulation mechanism of action for the treatment of cancer cachexia in the near future, as it will be the new trend in this market. The key participants operating in this market are Ã†terna Zentaris Inc., Aphios Corp., Alder BioPharmaceuticals Inc., Eli Lilly and Co., Helsinn Group, GTx Inc., Merck & Co. Inc., Bristol-Myers Squibb Co., Novartis AG, and XBiotech Inc., states the research report.\nPurchase your own copy of Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=15482&ltype=S\nThe review is based on a report by Transparency Market Research (TMR), titled \" Cancer Cachexia Market (Therapeutics - Progestogens and Corticosteroids Combination Therapies; Mechanism of Action - Appetite Stimulators, Weight Loss Stabilizers, Others; By distribution channels - Hospital Stores, Retail Pharmacy Stores, Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025. \"\nKey Takeaways\nThe demand for progestogens is comparatively higher and is expected to remain so over the next few years. The global market for cancer cachexia is led by North America.\nThe global cancer cachexia market has been segmented as follows:\nBy Therapeutics\nProgestogens Corticosteroids Combination Therapies Others\nBy Mechanism of action\nAppetite Stimulators Weight Loss Stabilizers Others\nBy Distribution Channel\nHospital Stores Retail Pharmacy Stores Online Pharmacy\nBy Geography\nNorth America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe Asia Pacific China Japan India Australia and New Zealand Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa South Africa GCC Countries Rest of MEA\nPopular Research Reports by TMR:\nCancer Biomarkers Market:\nhttps://www.transparencymarketresearch.com/cancer-biomarkers-market.html Tumor Ablation Market:\nhttps://www.transparencymarketresearch.com/tumor-ablation-market.html\nAbout Us\nTransparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.\nTMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.\nContact\nTransparency Market Research\nState Tower,\n90 State Street,\nSuite 700,\nAlbany NY - 12207\nUnited States\nTel: +1-518-618-1030\nUSA - Canada Toll Free: 866-552-3453\nEmail: sales@transparencymarketresearch.com\nWebsite : http://www.transparencymarketresearch.com\nResearch Blog : https://theglobalhealthnews.com/\nSOURCE Transparency Market Research", "external_links": ["https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=15482", "https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15482", "https://theglobalhealthnews.com/", "https://www.transparencymarketresearch.com/checkout.php?rep_id=15482&ltype=S", "https://www.transparencymarketresearch.com/cancer-cachexia-market.html", "http://www.transparencymarketresearch.com/", "https://www.transparencymarketresearch.com/cancer-biomarkers-market.html", "https://www.transparencymarketresearch.com/tumor-ablation-market.html"], "published": "2018-02-19T15:30:00.000+02:00", "crawled": "2018-02-19T17:05:12.007+02:00", "highlightTitle": ""}